Board of Directors


Robert Sambursky, MDRobert P. Sambursky, MD

Robert Sambursky has been a member of RPS’s executive leadership team as the Chief Medical Officer and served on the company’s Board of Directors since co-founding the company in 2004. In addition, he served as both President and Executive Chairman before being appointed the additional roles of CEO and Chairman. Sambursky currently serves on several pharmaceutical advisory boards. He earned his BA from Brown University, MA from Boston University, and MD from Boston University School of Medicine. Sambursky completed his medical internship at Mount Auburn Hospital and both his ophthalmology residency and cornea fellowship at Wills Eye Hospital in Philadelphia.

Stephen R. La Neve

Stephen La Neve has more than 30 years of healthcare industry experience during which he has served in various leadership roles in the medical device and diagnostics segments. Currently, La Neve is the co-founder and CEO of SkelRegen, a leader in small molecule musculoskeletal tissue regeneration. Most recently, La Neve was the president of Becton Dickinson’s Pre-Analytical Systems business, as well as president of Medtronic’s $3.5 billion Spine and Biologics business and its Japanese business unit, the company’s second largest country business unit. Additionally, La Neve has served in a number of commercial leadership positions at Roche Diagnostics, E Merck Diagnostic Systems, and in Becton Dickinson’s Point of Care Division. In these positions, La Neve has led sales, marketing, strategic planning, and project management efforts both in the U.S. and internationally. La Neve earned his BS in Health Planning and Administration from the Pennsylvania State University and an MBA from West Chester University.

Caroline Popper, MD, MPH

Caroline Popper is the founder and President of Popper and Company, a merger and acquisition life sciences consulting firm with clients across North America, Europe, and Asia.  She has more than 20 years of valuable POC industry experience as well as business management expertise spanning Fortune 500 companies and venture-backed startups. Additionally, Popper has managed a wide spectrum of life sciences businesses in diagnostics, devices, and digital health. In addition to RPS, Popper serves on the boards of NanoMR, Rarecyte, Pronota nv, and Innovative Biosensors. Popper received her MPH from Johns Hopkins University and her MD from the University of the Witwatersrand, South Africa. Additionally, Popper completed a Robert Wood Johnson Fellowship in Health Care Finance as well as residencies in Internal Medicine and in Pathology at Johns Hopkins.

Charles T. Saldarini

Charles Saldarini is an expert in biopharmaceutical services and a proven leader across all phases of growth and turnaround. He is currently the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Saldarini served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization’s sale to Accenture. Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Saldarini also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Saldarini also serves on the Syracuse University Board of Visitors and his local Board of Education. Saldarini earned his BA in Political Science and Communications Management from Syracuse University.

Daniel L. Sambursky, MD

For more than 15 years, Daniel Sambursky has been in private practice of ophthalmology in New York. Sambursky served as a Resident Instructor at the Manhattan Eye, Ear & Throat Hospital where he has taught numerous ophthalmologists his vision correction surgical techniques in refractive, cataract, and corneal surgery. Sambursky has co-authored several articles in various medical journals and has lectured around the world on ophthalmologic subjects including LASIK and cataract surgery. Sambursky has served on the RPS Board of Directors since the company’s inception. Sambursky earned his BS from Syracuse University, MS from Georgetown University, and MD from SUNY Health Science Center at Syracuse. He completed his internship at Strong Memorial Hospital in Rochester, New York and his residency at Manhattan Eye, Ear & Throat Hospital. Sambursky completed his fellowship in refractive and corneal surgery at the prestigious Wilmer Institute at Johns Hopkins Hospital.

Robert W. VanDine
Director, Secretary

Robert VanDine co-founded RPS during his tenure as President of Securetec Contraband Detection and Identification, Inc., the U.S. subsidiary of Securetec from 1996 to 2007. In this position, VanDine was responsible for the manufacture and marketing of lateral flow chromatography biosensors for the security, law enforcement, and medical device markets. Since 2007, VanDine has led the development of the RPS Intellectual Property portfolio and the company’s U.S. Government contracting efforts. He currently serves as Chief Government Affairs Officer. VanDine earned his BS from the U.S. Naval Academy.